Trium Capital LLP

SEC CIK: 0001963860
Latest filing: Jul 16, 2026

SEC filings (opens in a new tab)

ACRS holding history

Aclaris Therapeutics, Inc. in every 13F filed by Trium Capital LLP, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

ACRS overview All 13F holders of ACRS Full Q2 2026 holdings

Shares (Q4 2024): 0; Sold out in Q4 2024
Value: $0
% of portfolio: 0.0%
Quarters held: 2; Since Q2 2024

Holdings of ACRS by Trium Capital LLP, by quarter
Quarter	Shares	Value	% of portfolio	Share change	Action	All holders
Q4 2024	0	$0	0.0%	−1,912,990−100.0%	Sold out	Holders
Q3 2024	1,912,990	$2.20M	1.0%	+20,940+1.1%	Added	Holders
Q2 2024	1,892,050	$2.08M	0.7%	+1,892,050	New	Holders